TrialThe Lancet. Oncology2019
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Matthew Smith et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
186 papers cite itlatest 60 shown
this paperpooled ittrialcites it